Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Delhi HC Grants...

Delhi HC Grants Interim Relief to Mankind, Restrains AquaKind Labs from Using 'KIND' in Trademark

Farhat NasimWritten by Farhat Nasim Published On 2024-11-11T18:51:18+05:30  |  Updated On 11 Nov 2024 6:51 PM IST
Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORA
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In relief to Mankind Pharma, the Delhi High Court has granted an ex-parte interim injunction restraining AquaKind Labs LLP from using the "KIND" suffix in their trade name "Aquakind."

This ruling followed a trademark infringement lawsuit filed by Mankind Pharma Limited, which claimed that AquaKind Labs' use of the name was deceptively similar to its registered trademark "MANKIND," potentially causing confusion in the pharmaceutical market.

Mankind filed a lawsuit in the Delhi High Court, seeking to restrain AQUAKIND Labs LLP from using its trade name "AQUAKIND," claiming it infringes on Mankind Pharma’s registered trademarks. The plaintiff, represented by Senior Advocate Chander M. Lail and a team of lawyers, argued that the defendants' use of "AQUAKIND" is not only visually and phonetically similar to the well-known "MANKIND" trademark but also threatens to cause confusion in the pharmaceutical market.

The plaintiff has been using the "MANKIND" trademark since 1986, first under the name 'Mankind Pharma' and later as Mankind Pharma Limited, incorporated in 1991. Over the years, the company has developed a significant portfolio of trademarks incorporating the "KIND" suffix, which has become synonymous with high-quality pharmaceutical products. Mankind Pharma holds registrations for over 300 trademarks with the "KIND" suffix, including names such as HEPAKIND, GLYKIND, and METROKIND, establishing a solid market presence.

The dispute arose when Mankind Pharma discovered that AQUAKIND Labs had started using the trademark "AQUAKIND" for pharmaceutical products, which the plaintiff claims is deceptively similar to its own trademark. The plaintiff argued that this similarity is likely to cause confusion among consumers, especially since both companies operate in the same pharmaceutical space.

Mankind Pharma’s lawsuit also highlighted the malicious intent behind the defendants' adoption of "AQUAKIND." The company asserted that the use of a similar name is a deliberate attempt by the defendants to capitalize on the goodwill associated with "MANKIND" and "KIND." Furthermore, the plaintiff emphasized that such confusion in the pharmaceutical industry could have harmful consequences, as incorrect associations between similar products could jeopardize consumer safety.

As part of the case, Mankind Pharma sought an injunction to prevent the defendants from using the "AQUAKIND" trademark and is also requesting damages and the rendition of accounts for the alleged infringement.

Examining the case, the court observed that the plaintiff, Mankind Pharma, had successfully demonstrated a prima facie case for the grant of an injunction. The court further noted that if no ex parte ad interim injunction were issued, the plaintiff would suffer irreparable harm. The balance of convenience, according to the court, clearly tilted in favor of the plaintiff and against the defendants. It observed;

“The plaintiff has demonstrated a prima facie case for grant of injunction and, in case, no ex parte ad interim injunction is granted, the plaintiff will suffer an irreparable loss. Further, balance of convenience also lies in favour of the plaintiff, and against the defendants.”

In its order, the court prohibited the defendants—AQUAKIND Labs LLP and its affiliates—from selling, advertising, or dealing in any goods or services under the trade name "AQUAKIND" or any trademark that could be confused with Mankind Pharma’s registered trademarks, "MANKIND" and its related "KIND" variants. It noted;

“Accordingly, till the next date of hearing, the defendants, their proprietors, partners or directors, as the case may be, its principal officers, servants, distributors, dealers and agents, and all others acting for and on behalf of the defendants, are restrained m selling, offering for sale, advertising, directly or indirectly dealing 4fiyf gqOds and services under the impugned trade mark/ trade name "AQUAKIND"/ "AQUAKIND LABS LLP' and or any other trade mark/trade name as may be identical to or deceptively similar with the plaintiff's registered trademarks "MANKIND" and/ or "KIND" formative trademarks and their variants thereof, so as to cause infringement as well as passing off of the plaintiff s trademarks.”

Additionally, the court addressed the need for evidence preservation and appointed two Local Commissioners to inspect the defendants’ premises. These commissioners are tasked with seizing any infringing products and gathering financial records that relate to the sale of these products.

The case has been scheduled for further proceedings in December 2024, with a final hearing set for March 2025.

To view the original judgement, click on the link below:

https://medicaldialogues.in/pdf_upload/order-260284.pdf
mankind pharmaaquakind labsdelhi high courttrade nametrade mark infringementtrade mark protection
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 30/May/2025

    Health Bulletin 30/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok